Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.130 | 3.310 | 1.180 |
Shares | 97.870 | 97.870 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 31.720 | 37.516 |
Price to Book | 3.965 | 5.365 |
Price to Sales | 4.253 | 5.581 |
Price to Cash Flow | 21.381 | 27.701 |
Dividend Yield | 0.584 | 0.595 |
5 Years Earnings Growth | 21.429 | 19.762 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.740 | 96.130 |
Basic Materials | 1.350 | 4.357 |
Financial Services | 0.910 | 1.163 |
Number of long holdings: 45
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 14.35 | 1,795.30 | +0.86% | |
Dr Reddy’s Laboratories | INE089A01031 | 9.03 | 1,214.45 | +1.60% | |
Cipla | INE059A01026 | 8.07 | 1,486.50 | +1.43% | |
Lupin | INE326A01037 | 4.59 | 2,071.35 | +1.39% | |
Aurobindo Pharma | INE406A01037 | 4.57 | 1,223.70 | +0.30% | |
Gland | INE068V01023 | 4.22 | 1,755.05 | -1.79% | |
Apollo Hospitals | INE437A01024 | 3.80 | 6,935.10 | +2.86% | |
Zydus Lifesciences | INE010B01027 | 2.93 | 949.05 | +0.53% | |
Divi's Labs | INE361B01024 | 2.69 | 5,998.35 | +0.36% | |
Biocon | INE376G01013 | 2.39 | 331.50 | +2.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICICI Focused Bluechip Equity RetGr | 636.7B | 19.57 | 17.19 | 14.12 | ||
ICICI Focused Bluechip Eq RetailDiv | 636.7B | 18.88 | 16.39 | 13.30 | ||
ICICI Prud Focused Bluechip Div | 636.7B | 19.95 | 17.65 | 14.65 | ||
ICICI Prud Focused Bluechip Gr | 636.7B | 20.15 | 17.90 | 14.99 | ||
ICICI Balanced Adv Dir Div | 605.45B | 13.16 | 12.53 | 11.67 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review